Oramed’s oral insulin flunks phase 3 diabetes test, sending stock down 70% FierceBiotech
source
Oramed's oral insulin flunks phase 3 diabetes test, sending stock down 70% – FierceBiotech
Byadmin
Jan 13, 2023
Diabetes information
Oramed’s oral insulin flunks phase 3 diabetes test, sending stock down 70% FierceBiotech
source